165 related articles for article (PubMed ID: 27364549)
1. Heart rate control by carvedilol in Japanese patients with chronic atrial fibrillation: The AF Carvedilol study.
Inoue H; Atarashi H; Okumura K; Yamashita T; Fukuzawa M; Shiosakai K; Kimura T
J Cardiol; 2017 Jan; 69(1):293-301. PubMed ID: 27364549
[TBL] [Abstract][Full Text] [Related]
2. Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation.
Ulimoen SR; Enger S; Carlson J; Platonov PG; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
Am J Cardiol; 2013 Jan; 111(2):225-30. PubMed ID: 23111138
[TBL] [Abstract][Full Text] [Related]
3. Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: results of the MAIN-AF study.
Yamashita T; Inoue H
J Cardiol; 2013 Jul; 62(1):50-7. PubMed ID: 23611172
[TBL] [Abstract][Full Text] [Related]
4. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
[TBL] [Abstract][Full Text] [Related]
6. Effects of carvedilol on cardiac autonomic nerve activities during sinus rhythm and atrial fibrillation in ambulatory dogs.
Choi EK; Shen MJ; Lin SF; Chen PS; Oh S
Europace; 2014 Jul; 16(7):1083-91. PubMed ID: 24469435
[TBL] [Abstract][Full Text] [Related]
7. Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study).
Yamashita T; Ikeda T; Akita Y
J Cardiol; 2019 May; 73(5):386-393. PubMed ID: 30591320
[TBL] [Abstract][Full Text] [Related]
8. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?
Khand AU; Rankin AC; Martin W; Taylor J; Gemmell I; Cleland JG
J Am Coll Cardiol; 2003 Dec; 42(11):1944-51. PubMed ID: 14662257
[TBL] [Abstract][Full Text] [Related]
9. Circadian variation of variability and irregularity of heart rate in patients with permanent atrial fibrillation: relation to symptoms and rate control drugs.
Corino VD; Platonov PG; Enger S; Tveit A; Ulimoen SR
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(12):H2152-7. PubMed ID: 26497961
[TBL] [Abstract][Full Text] [Related]
10. A frequent gene polymorphism affecting the heart-rate response to carvedilol.
Eschenhagen T
Pharmacogenomics; 2013 Jan; 14(2):115-8. PubMed ID: 23327570
[No Abstract] [Full Text] [Related]
11. Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily Immediate-Release Carvedilol IR in Patients with Heart Failure (CASPER) Trial.
Udelson JE; Pressler SJ; Sackner-Bernstein J; Massaro J; Ordronneau P; Lukas MA; Hauptman PJ
J Card Fail; 2009 Jun; 15(5):385-93. PubMed ID: 19477398
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation: adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction.
Boriani G; Biffi M; Diemberger I; Domenichini G; Marziali A; Martignani C
Int J Cardiol; 2010 Apr; 140(2):242-3; author reply 243-4. PubMed ID: 19062111
[TBL] [Abstract][Full Text] [Related]
13. [Prospective evaluation of effect of carvedilol therapy on heart rate variability in patients with dilated cardiomyopathy].
Hoffmann J; Grimm W; Menz V; Hufnagel G; Maisch B
Z Kardiol; 1999 Sep; 88(9):653-60. PubMed ID: 10525927
[TBL] [Abstract][Full Text] [Related]
14. The effect of carvedilol on B-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation.
Khand AU; Chew PG; Douglas H; Jones J; Jan A; Cleland JG
Cardiology; 2015; 130(3):153-8. PubMed ID: 25660493
[TBL] [Abstract][Full Text] [Related]
15. Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects.
Valentini M; Revera M; Bilo G; Caldara G; Savia G; Styczkiewicz K; Parati S; Gregorini F; Faini A; Branzi G; Malfatto G; Magrì D; Agostoni P; Parati G
Cardiovasc Ther; 2012 Aug; 30(4):240-8. PubMed ID: 21883997
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of carvedilol in unstable angina pectoris.
Brunner M; Faber TS; Greve B; Keck A; Schnabel P; Jeron A; Meinertz T; Just H; Zehender M
Am J Cardiol; 2000 May; 85(10):1173-8. PubMed ID: 10801996
[TBL] [Abstract][Full Text] [Related]
17. Do metoprolol and carvedilol have equivalent effects on diurnal heart rate in patients with chronic heart failure?
Sanderson JE; Leung LY; Chan SK; Yip GW; Fung JW; Yu CM
Eur J Heart Fail; 2005 Aug; 7(5):874-7. PubMed ID: 16043407
[TBL] [Abstract][Full Text] [Related]
18. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.
Metra M; Torp-Pedersen C; Swedberg K; Cleland JG; Di Lenarda A; Komajda M; Remme WJ; Lutiger B; Scherhag A; Lukas MA; Charlesworth A; Poole-Wilson PA
Eur Heart J; 2005 Nov; 26(21):2259-68. PubMed ID: 16040619
[TBL] [Abstract][Full Text] [Related]
19. Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients.
Rau T; Düngen HD; Edelmann F; Waagstein F; Lainščak M; Dimković S; Apostolović S; Nešković AN; Haverkamp W; Gelbrich G; Eschenhagen T
Clin Pharmacol Ther; 2012 Jul; 92(1):21-8. PubMed ID: 22617224
[TBL] [Abstract][Full Text] [Related]
20. Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation.
Ulimoen SR; Enger S; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
Eur Heart J; 2014 Feb; 35(8):517-24. PubMed ID: 24135831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
